How to fund therapeutic virtual reality at your institution: budget, grants and alternatives to buying

When a healthcare institution recognises the value of therapeutic virtual reality, the brake that shows up next is rarely technical or clinical. It is financial — but not in the way people assume. The problem is usually not the price; it is how to pay it. And here there are more options than a direct purchase.

First: is it reimbursed?

Let's be clear. In general, therapeutic virtual reality does not have direct patient reimbursement the way a prescribed medicine does. It is acquired by the institution — hospital, clinic, care home, non-profit — as equipment and a working tool. In other words: funding happens on the organisation's side, not the patient's.

That is not bad news. It just means the right route is not a prescription, it is investment — and investment has several doors.

The funding routes

There is no single way to pay. The most common:

• Internal budget — the most direct route, especially when framed as improving patient experience and team efficiency.
• Fund applications — innovation, modernisation or digitalisation programmes in healthcare an institution can apply to. These change over time; it is worth confirming which are open.
• Social-sector support — non-profits and care homes sometimes have their own lines of support for equipment investment.
• Rental or subscription — instead of buying, you pay a recurring amount. It avoids upfront investment and turns it into predictable operating cost.
• Pilot programme — test in one service before scaling, reducing risk.

The right question is not "do we have the budget to buy?" — it is "which of these routes fits our cash flow and our type of institution?".

Why testing first makes sense

The return of virtual reality in healthcare depends, above all, on use. Equipment bought and then forgotten is the worst scenario. So models that let you test before investing — a short rental, a pilot in one service — protect the decision: they validate team adoption and real value before a bigger commitment.

The role of RVer

RVer is an immersive virtual reality therapy system designed for healthcare environments and certified as a Class I Medical Device by Infarmed, in compliance with the European regulation MDR 2017/745. It is built to lower the barrier to entry: it runs on affordable standalone headsets, is simple to operate and manage, and collects no patient clinical data — which makes it easy to start small, test and grow.

Price is rarely the real obstacle. Knowing the funding routes is what turns a "we'd like to" into a "let's go ahead".

← Back to the blog